EA Weeks, Ph.D., counsel in Troutman Pepper Locke’s Health Care + Life Sciences Practice Group, was a guest on Cell & Gene: The Podcast. EA joined host Erin Harris to discuss the deal terms most critical to cell and gene therapy (CGT) transactions, including intellectual property ownership, manufacturing as a key value-driver, and regulatory considerations, among other topics shaping the current CGT deal landscape. They also discussed planning for what happens when a partnership does not go as expected.

Listen to the full episode on Apple Podcasts, Spotify, and YouTube.

Insight Industries + Practices